We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Deltex Medical Group Plc | LSE:DEMG | London | Ordinary Share | GB0059337583 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.135 | 0.13 | 0.14 | 0.135 | 0.135 | 0.14 | 100,000 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electromedical Apparatus | 2.48M | -1.15M | -0.0006 | -2.17 | 2.4M |
Date | Subject | Author | Discuss |
---|---|---|---|
05/1/2018 12:29 | Now all depends what the placing price is going to be at. | knowing | |
05/1/2018 11:46 | Goes from bad to worse - 40% fall in a day - has to be the worst ever one day move in this share. | trentendboy | |
05/1/2018 11:37 | Signs of pipeline blockages easing in Q4 2017. First revenues generated from three new potentially large accounts | escapetohome | |
05/1/2018 11:15 | Could there a potential low bid offer for the company considering the current circumstance - I wonder if one of the big players could make use of this market - It's clear the current management will not be able to by the looks of things - | tomboyb | |
05/1/2018 11:10 | I agree with yump and also now written off my investment. I thought the product offered significant promise some time ago however the updates and results always provided a superficial gloss to a deteriorating performance I believe the management strategies and corrective actions have been woeful. They lack commercial judgement and focus is there for all to see. A target panel of hospitals in US was reached yet the sales do not flow.....in essence they have diluted the sales effort and increased costs. | catch007 | |
05/1/2018 10:47 | I never did ‘pounce’ and now i never will! A ghost company! | escapetohome | |
05/1/2018 10:40 | With a market cap of £3million what about someone buying the company out - This looked very good on paper a few years ago with some great research - | tomboyb | |
05/1/2018 09:28 | Agree with your sentiments, let's see what shape the fund raising is, if anything I would like to see something larger than they normally do or get some kind of strategic investor with a US tilt..........gutted to be fair | chrisdgb | |
05/1/2018 09:18 | Interesting that the price started falling from 4p in July after what was a promising update, so obviously not believed at that time. The drop in sales from a couple of the US areas shown in the AGM presentation may well be what put the wind up people as that was evidence that if you slow the sales effort, the sales drop drastically - so the prospect of a gravy train of probe sales with reduced sales efforts in the future was dead in the water. Probably should have sold then but stake already reduced to a level where it didn't matter. Well it did matter, but not overall. More disappointed that they appeared to have something good and seem to have gone nowhere with it. | yump | |
05/1/2018 08:37 | What a disappointment. It is hard to see this surviving. | gnnmartin | |
05/1/2018 07:34 | I reckon its a dead duck now and written off my investment. Suppose its possible that they might squeeze a tiny profit given time. If there was going to be 'momentum' in the US it would have happened by more than 5% by now, given the length of time many accounts have been running for, so talk of momentum next year is imo a load of tosh and continuing sales effort with every US account will mean cost of sales will not drop significantly. It appears that ODM just has trouble selling in sufficient volume for very long, regardless of whether hospitals have funding issues or not. Unfortunately it was a long time to wait for nothing. No doubt some of the earlier doomsters will say they are now proved right - but it would have be very silly to just take the word of a few posters as evidence, rather than the actual facts of the business. | yump | |
05/1/2018 07:26 | That's a terrible update. With all the accounts that have been opened over the last year or so, turnover in the states should be powering ahead. Does not bode well for the future | reallyrich | |
05/1/2018 07:24 | Bigger than expected loss Profit warning | larva | |
05/1/2018 07:20 | Groundhog Day! "We have substantially reduced our rate of operating cash consumption in order to meet our key goal of getting past the operating cash breakeven point. In the final quarter of 2017 we put in place a number of changes to our cost base with effect from the start of 2018 and, in view of the actual level of 2017 sales, we are reducing our costs further to match our operating cash costs with current levels of sales. These actions should allow us to fund future organic growth out of operating cash flows." | mickharkins1 | |
03/1/2018 20:14 | A truly dreadful performance - something has to change (or it will be too late). It is a shame | trentendboy | |
03/1/2018 20:07 | 1.9p EP should walk If he were a football manager he’d be long gone | myosite | |
02/1/2018 11:53 | Perhaps folk have reached the conclusion that although the UK problems could be explained by NHS limitations, the lacklustre sales increases from the US are showing that probe sales will not simply increase just because a hospital has a monitor. Clearly revenue growth is not driving the business, which is why their statements are often about cash and breakeven. ie. it may have got to the point where survival without constant placings is unlikely, without changing the business model to include selling anything to anyone that will take it. Perhaps that is what they should have been doing all along or perhaps the US will actually show some more meaningful probe sales growth and show that the model will work, but very slowly. I doubt that, because the removal of the sales effort in at least one area, led to sales contraction, judging by the presentation slides and they mentioned that in the last update. At best, it looks like very slow growth, with a very careful balancing act between the cost of sales effort vs. the growth actually achieved. It wouldn't take much continual growth across US accounts to make a big difference to revenue increases. I think that should have happened by now, given the length of time many US accounts have been running. | yump | |
02/1/2018 09:24 | 21 days with no post on the other board. Have they really all cashed out?A12 percent fall does not even raise one post ??? | trentendboy | |
11/12/2017 23:15 | I continue to stalk this share waiting to pounce! | escapetohome | |
11/12/2017 22:18 | Oh no it's not! | supernumerary | |
11/12/2017 21:57 | Behind you | myosite | |
11/12/2017 19:43 | Oh no it wouldn't! | supernumerary | |
11/12/2017 17:46 | This would break even the heart of the hardest investor. | arf dysg |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions